Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Drug industry

Article Abstract:

Statistics of some of the companies in the Drug industry and their securities rankings as of January 20, 2006 are furnished. The adverse conditions prevailing in USA are expected to force the government to formulate policies conducive to this sector as the industry forms a very critical part of the countryEs economy. Consequently, the industry and its stocks are expected to gain.

Author: Rho, George, Ferro, Mario, Schlein, Milton, Clark, Charles, Butler, Jeremy J., Markey, Keith A., Rosner, Adam
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2006
Forecasts, trends, outlooks, Industry Overview, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Andrx

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Andrx from 1996 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

Author: Rosner, Adam
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Company sales and earnings, Company earnings/profit, Andrx Corp., ADRX

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Pharmaceutical industry, Securities, Company securities
Similar abstracts:
  • Abstracts: Drugstore industry. Rite Aid Corp
  • Abstracts: Drug industry. Chemical (basic) industry
  • Abstracts: Abgenix Inc. Drug industry
  • Abstracts: Albany Molecular. Albany Molecular Research
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.